197 related articles for article (PubMed ID: 1681356)
1. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
Takano S; Omata M; Ohto M; Nakamura K
Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
[TBL] [Abstract][Full Text] [Related]
4. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
5. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
Takano S; Omata M; Ohto M; Satomura Y
Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
8. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
Ebeling F
Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
12. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiologic studies of hepatitis C virus infection in a population of Okayama Prefecture screened for liver disease.
Uesugi S; Taketa K; Rimal N; Ikeda S; Kariya T; Suganuma N; Yamamoto H; Kira S
Acta Med Okayama; 1999 Feb; 53(1):31-8. PubMed ID: 10096736
[TBL] [Abstract][Full Text] [Related]
16. Post-transfusion hepatitis C virus infection.
Kleinman S; Busch M; Holland P
N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
[No Abstract] [Full Text] [Related]
17. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
Janot C
Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
[No Abstract] [Full Text] [Related]
18. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
[TBL] [Abstract][Full Text] [Related]
19. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
[TBL] [Abstract][Full Text] [Related]
20. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
